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M Protein, a Classical Bacterial Virulence
Determinant, Forms Complexes with Fibrinogen
that Induce Vascular Leakage
motactic signal, the PMNs become adherent and attach
firmly to the endothelium. The cells then start to extrava-
sate into the infected tissue where they phagocytose
invading bacteria. These adhesion processes involve
the sequential engagement of a number of different ad-
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mediate firm adhesion to the endothelium, such as the
ICAMs, but also various plasma proteins including C3bi,
factor X, and fibrinogen (for a review, see Crockett-Summary
Torabi, 1998). The interaction between fibrinogen and
2 integrins is regulated by divalent cations (Yan et al.,Increased vascular permeability is a key feature of
1995), and whereas soluble fibrinogen binds only to acti-inflammatory conditions. In severe infections, leakage
vated PMNs, immobilized fibrinogen can also interactof plasma from the vasculature induces a life-threaten-
with unstimulated PMNs (Yan et al., 1995).ing hypotension. Streptococcus pyogenes, a major hu-
Streptococcus pyogenes is a significant humanman bacterial pathogen, causes a toxic shock syn-
pathogen giving rise to a wide spectrum of diseasesdrome (STSS) characterized by excessive plasma
ranging from uncomplicated infections, such as pharyn-leakage and multi-organ failure. Here we find that M
gitis, impetigo, and erysipelas, to life-threatening condi-protein, released from the streptococcal surface,
tions associated with shock and organ failure. S. pyo-
forms complexes with fibrinogen, which by binding to
genes expresses substantial amounts of M protein,
2 integrins of neutrophils, activate these cells. As a -helical coiled-coil surface proteins (for a review, see
result, neutrophils release heparin binding protein, an Fischetti, 1989), which represents one of the classical
inflammatory mediator inducing vascular leakage. In virulence determinants of S. pyogenes promoting the
mice, injection of M protein or subcutaneous infection survival of the bacterium in human blood (Lancefield,
with S. pyogenes causes severe pulmonary damage 1969). Apart from being associated with the bacterial
characterized by leakage of plasma and blood cells. cell wall, M protein is also released from the surface
These lesions were prevented by treatment with a 2 by the action of a cysteine proteinase secreted by the
integrin antagonist. In addition, M protein/fibrinogen bacteria (Berge and Bjo¨rck, 1995). Several reports have
complexes were identified in tissue biopsies from a shown that M protein binds fibrinogen (Kantor, 1965)
patient with necrotizing fasciitis and STSS, further un- with high affinity (A˚kesson et al., 1994). Here, we find
derlining the pathogenic significance of such com- that M protein/fibrinogen complexes interact with 2 in-
plexes in severe streptococcal infections. tegrins and activate PMNs. This results in a massive
inflammatory response with profound pathophysiologi-
Introduction cal consequences, which helps to explain the symptoms
of streptococcal toxic shock syndrome (STSS), one of
Polymorphonuclear neutrophils (PMNs) are part of the the most acute and severe forms of septic shock.
first line of defense against bacterial infections. Under
physiological conditions nonactivated PMNs circulate Results
in the bloodstream. However, once activated by a che-
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To test whether M1 protein is released from the strepto-5 Present address: Omnicare Clinical Research GmbH, D-65824
Schwalbach/Ts., Germany. coccal surface following treatment with human neutro-
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Figure 1. Release of M1 Protein from the
Streptococcal Surface Following Treatment
with Supernatants from Stimulated PMNs
(A) AP1 bacteria (2  109 bacteria/ml) were
incubated with a serial dilution (100 l, 10 l,
or 1 l; lanes 2–4) of exudate from stimulated
PMNs (2 106 cells/ml, see also Experimental
Procedures) for 2 hr at 37C. As a control,
the bacteria were incubated with buffer alone
(lane 1). Bacteria were centrifuged and the
resulting supernatants were run on SDS-
PAGE. Separated proteins were transferred
onto nitrocellulose and probed with antibod-
ies to M1 protein. Bound antibodies were de-
tected by peroxidase-conjugated secondary
antibodies to rabbit immunoglobulin.
(B) 10 ng purified M1 protein (lane 1), AP1
surface proteins released with 100 l neutro-
phil secretion products (lane 2), and 10 ng
purified protein H (lane 3) were subjected to
SDS-PAGE. After transfer onto nitrocellulose
membranes, the membranes were incubated
with fibrinogen (2 g/ml) followed by immu-
nodetection with rabbit antibodies to human
fibrinogen and a peroxidase-conjugated sec-
ondary antibody against rabbit immuno-
globulin.
(C) Transmission electron microscopy of thin
sectioned AP1 bacteria before incubation
with exudate from stimulated PMNs.
(D) AP1 bacteria after incubation with 2  108
bacteria in 100 l PMN exudate. Bar is equal
to 1 m.
phil proteinases, bacteria of the M1 serotype (AP1) were specificity of the antibody (data not shown). As men-
tioned above, M protein has an affinity for fibrinogen andincubated with serial dilutions of secretion products
from PMNs stimulated by antibody-crosslinking of in the AP1 strain, the M1 protein is the only fibrinogen
binding molecule (Berge and Bjo¨rck, 1995; Herwald etCD11b/CD18. As described previously, activation of the
2 integrins by antibody-crosslinking mimics adhesion- al., 2003; Kihlberg et al., 1995). To test whether the gen-
erated M1 protein fragments were still capable of bind-dependent receptor engagement and induces the re-
lease of neutrophil elastase, cathepsin G, and protein- ing fibrinogen, streptococcal proteins released by neu-
trophil exudate were run on SDS-PAGE and transferredase 3 (Gautam et al., 2000). This was confirmed in the
present study using an indirect ELISA (data not shown). onto nitrocellulose. Filters were probed with fibrinogen
followed by immunodetection with specific antibodiesIncubation of AP1 bacteria with neutrophil exudates re-
sults in the release of several streptococcal surface pro- against fibrinogen. Whereas M1 protein binds fibrino-
gen, the closely related protein H does not (A˚kesson etteins as determined by SDS-PAGE (data not shown).
The presence of M1 protein was analyzed by Western al., 1994). This is demonstrated in Figure 1B, which also
shows that treatment with secreted neutrophil protein-blot analysis using a polyclonal antiserum against M1
protein. Figure 1A shows that in the absence of secreted ases releases several fibrinogen binding peptides from
AP1 bacteria (Figure 1B, lane 2). The molecular massesneutrophil components, only small amounts of M1 pro-
tein are released from the bacterial surface, whereas of these peptides correlate well with the M1 protein
fragments seen in Figure 1A. Identical membranes thatlarger quantities of M1 protein fragments with different
molecular masses were detected when bacteria were were incubated with the antifibrinogen antibodies alone
failed to give any reactivity, showing that the antibodiesincubated with increasing volumes of neutrophil secre-
tion products. A size-comparison of the largest M1 pro- do not crossreact with neutrophil or streptococcal com-
ponents (data not shown). Transmission electron mi-tein fragment with intact M1 protein suggests that it
covers most, if not all, of the extracellular part of the croscopy analyses of thin-sectioned AP1 bacteria be-
fore and after incubation with neutrophil exudates,molecule. With increasing concentrations of neutrophil
secretion products, M1 protein was further degraded revealed that the secreted proteinases efficiently re-
move the fibrous surface proteins of AP1 bacteria (Fig-(Figure 1A). In the absence of bacteria, neutrophil secre-
tion products probed with antiserum against M1 protein ures 1C and 1D). In the AP1 strain, these hair-like struc-
tures represent M1 protein and protein H (Kihlberg et al.,failed to show immunoreactivity, demonstrating the
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1995), and the results show that neutrophil proteinases cated signal transduction machinery (Borregaard and
release M1 protein fragments with retained fibrinogen Cowland, 1997). To investigate by which mechanism M1
binding activity from the bacterial surface. protein induces mobilization of HBP in human blood,
the influence of signal transduction inhibitors on HBP
M1 Protein Triggers the Release of Heparin release was analyzed. Theoretically, fMLP contamina-
Binding Protein (HBP) from PMNs in Human Blood tion of the M1 protein preparation could cause activation
The only blood cells that were reported to produce the of PMNs. Therefore the first substances tested were
inflammatory mediator HBP are PMNs (Edens and t-boc-MLP (an fMLP antagonist) and pertussis toxin.
Parkos, 2003). The observation that fragments of M1 This toxin is an antagonist of Gi protein-coupled seven
protein were released by neutrophil proteinases raised membrane-spanning receptors, and fMLP receptors
the question whether these fragments and/or other S. also belong to this group of receptors. As shown in
pyogenes components could enhance the inflammatory Table 1, neither of the two components inhibited the
response by releasing HBP from PMNs. Soluble strepto- release of HBP in blood, implicating that fMLP was not
coccal components were therefore added to human present in the M1 protein preparation and that M1 pro-
whole blood and the HBP release was measured. Figure tein does not act as an fMLP receptor agonist. The
2A shows that approximately 60% of the HBP stored next signal transduction inhibitors to be tested were
in PMNs is mobilized when M1 protein (1 g/ml final genistein, a tyrosine kinase inhibitor, and wortmannin, a
concentration) is added to blood (diluted 1/10). Interest-
phosphatidylinositol 3-kinase inhibitor. These inhibitors
ingly, both lower and higher concentrations of M1 pro-
abrogate downstream effects of 2 integrin-triggeredtein resulted in less efficient HBP release. Apart from
PMN signaling (Axelsson et al., 2000), and both sub-M1 protein, formyl-methionyl-leucyl-phenylalanine (fMLP)
stances blocked the release of HBP. To study the effectand to a lesser extent lipoteichoic acid (LTA) and protein
of intracellular and extracellular calcium, BAPTA-AMH, also evoked secretion of HBP. Hyaluronic acid (HA),
(complexing intracellular calcium) and EGTA (complex-which is part of the streptococcal capsule, and the se-
ing extracellular calcium) were added to the blood. Likecreted streptococcal proteins SpeB and protein SIC,
genistein and wortmannin, this treatment inhibited thedid not induce HBP secretion. In order to exclude the
mobilization of HBP. When EGTA was used in the ab-possibility that the HBP release is caused by LPS con-
sence of BAPTA-AM, it also blocked HBP release. Thesetamination, purified LPS was tested as a control. How-
results suggest that the M1 protein-induced release ofever, even at a high concentration (10 g/ml) LPS failed
HBP is dependent on divalent metal ions. Other inhibi-to induce the release of HBP from PMNs.
tors, such as AG1478, a selective inhibitor of EGF recep-To localize the region in the M1 protein that triggers
tor tyrosine kinase, GF109203, a protein kinase C inhibi-secretion of HBP from PMNs, fragments A-S and S-C3
tor, H-89, an inhibitor of cAMP-dependent proteinof M1 protein (A˚kesson et al., 1994) were tested. Figure
kinase, PD98059, an inhibitor of the MAPK pathway, and2B shows that fragment A-S mobilizes HBP whereas
U-73122, a phospholipase C inhibitor, did not interferefragment S-C3 has no effect, demonstrating that the
with the secretion of HBP. Taken together, the resultsNH2-terminal part of the M1 protein is sufficient for HBP
release. Previous studies have mapped fibrinogen bind- suggest that the release of HBP in human blood induced
ing to the B domains of fragment A-S, albumin binding by M1 protein is dependent on the interaction with a
sites to the C repeats of S-C3, and IgG Fc binding activity receptor-like structure at the neutrophil surface. The
to the S region, which is present in both fragments (A˚kes- data also demonstrate that this interaction is dependent
son et al., 1994; Ringdahl et al., 2000). The M1 protein on extracellular divalent metal ions.
and its two fragments (A-S and S-C3), used for the stimu-
lation of PMNs, are recombinant proteins produced in
E. coli. However, M1 protein produced by S. pyogenes M1 Protein Precipitates Fibrinogen in Plasma
also releases HBP, as shown with an isogenic AP1 mu- To identify a putative neutrophil receptor mediating the
tant strain, termed MC25, expressing a truncated M1 release of HBP in blood, binding of 125I-M1 protein to
protein lacking the COOH-terminal cell-wall-anchoring purified PMNs was tested. No binding to the PMNs was
motif. This strain has no surface bound M1 protein, but detected, suggesting that the interaction requires a co-
produces an M1 protein fragment covering the surface- factor, presumably a plasma protein. However, one of
exposed part of the molecule, including the fibrinogen
our initial observations was that the addition of M1 pro-
binding B domains, that is secreted into the growth
tein (at a concentration of 1 g/ml) to plasma (dilutedmedium (Collin and Olse´n, 2000). Figure 2C shows that
1/10) provoked a visible precipitate, while at other con-supernatants of an overnight culture from MC25 bacteria
centrations of M1 protein no precipitate was formed inwhen added to human blood, trigger the release of HBP,
the plasma sample. The results of Figure 3A show thatwhile culture supernatants from AP1 bacteria or growth
125I-M1 protein is coprecipitated when added togethermedium alone, did not have this effect. The results dem-
with unlabeled M1 protein to plasma at the critical con-onstrate that soluble M1 protein, produced by E. coli or
centration. Maximal release of HBP from PMNs was alsoS. pyogenes, induces HBP release in human blood.
recorded at an M1 protein concentration of 1 g/ml
in blood diluted 1/10 (Figure 3B), suggesting that M1The Release of HBP from Human Blood PMNs
precipitation and HBP release are correlated. The obser-Is Modulated by Signal Transduction Mediators
vation that M protein forms insoluble complexes in hu-and Extracellular Divalent Metal Ions
man plasma was reported already in 1965, and wasPMNs release their granular content upon cell lysis or
by regulated secretory mechanisms involving sophisti- found to be the result of interactions between M protein
Cell
370
Figure 2. Release of HBP in Human Blood
(A) Human blood was incubated with M1 pro-
tein, protein H, SpeB, protein SIC, fMLP, lipo-
teichoic acid (LTA), hyaloronic acid (HA), or
LPS for 30 min at 37C. Cells were pelleted
and the concentration of HBP in the superna-
tants was determined by ELISA. The total
amount of HBP in blood was determined by
lysing cells with Triton X-100, and the amount
of HBP released after incubation for 30 min
at 37C without stimulation, was considered
as background. The figure presents the
mean SD of three independently performed
experiments, each done in duplicate.
(B) M1 protein, M1 protein fragments A-S and
S-C3 (schematically depicted at the top), or
protein H, was added to human blood, fol-
lowed by incubation for 30 min at 37C. Cells
were pelleted and the concentration of HBP
in the supernatants was determined by
ELISA. The figure presents the mean  SD of
three independently performed experiments,
each done in duplicate.
(C) Serial dilutions of supernatants from over-
night cultures of strains AP1 and MC25, or
growth medium alone, were added to human
blood and the release of HBP was deter-
mined.
and fibrinogen (Kantor, 1965). The interaction between ine proteinase inhibitors did not influence M1 protein-
induced precipitation, indicating that a thrombin-likepurified M1 protein and purified fibrinogen was therefore
investigated, and also in buffer precipitates were formed cleavage of fibrinogen did not cause the precipitation
(data not shown). Scanning electron microscopy re-at the same concentrations of M1 protein and fibrinogen
as in plasma (Figure 3C). In contrast, no precipitation vealed amorphous aggregates (Figure 3D), whereas
plasma clots induced by thrombin showed networks ofoccurred when M1 protein was added to fibrinogen-
deficient plasma (data not shown). The presence of ser- fibrin fibrils similar to those described previously (Her-
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Table 1. Influence on M1 Protein-Induced Release of HBP in Human Blood by Various Signal Transduction Inhibitors
M1 protein-induced release
Inhibitor Target (percent  SEM)a
t-boc-MLP fMLP receptor 110,7  6,2
pertussis toxin Gi protein-coupled seven membrane spanning receptors 135,7  5,1
genistein tyrosine kinases 12,7  8,4
wortmannin phosphatidylinositol 3-kinase 3,0  1,3
BAPTA and EGTA intra- and extracellular calcium 1,6  4,0
EGTA extracellular calcium 1,3  4,0
AG1478 EGF receptor tyrosine kinase 103,0  8,7
GF109203 protein kinase C 116,0  5,3
H-89 cAMP-dependent protein kinase 137,7  9,8
PD98059 MAPK pathway 108,0 20,0
U-73122 phospholipase C 83,7  22,4
a The release induced by M1 protein corresponds to 100 percent.
wald et al., 2003). The results demonstrate that M1 pro- covered with an amorphous protein layer (Figure 4A,
upper left), similar to the M1 protein/fibrinogen precipi-tein, when added to human plasma within a narrow con-
centration range, has the potential to induce the tates seen in Figure 3D. No protein precipitates or cell
aggregates were found when PMNs were reconstitutedformation of M1 protein/fibrinogen precipitates. These
precipitates are morphologically different from physio- with plasma in the absence of M1 protein (Figure 4A,
upper right), or when PMNs were treated with M1 proteinlogical clots induced by thrombin.
dissolved in buffer instead of plasma (Figure 4A, lower
left). Purified PMNs incubated with buffer alone servedM1 Protein/Fibrinogen Complexes Activate PMNs
as a control (Figure 4A, lower right). Additional experi-In another set of experiments, we analyzed the interac-
ments with normal and fibrinogen-deficient plasma re-tion between M1 protein/fibrinogen complexes and
vealed that the aggregation of PMNs in the presence ofPMNs by scanning electron microscopy. Figure 4A
M1 protein is fibrinogen-dependent (data not shown).shows that PMNs reconstituted with a mixture con-
taining M1 protein and plasma form aggregates that are The results indicate that the interaction between PMNs
Figure 3. M1 Protein-Induced Release of
HBP Correlates with M1 Protein-Induced Pre-
cipitation of Plasma
(A) Samples of 10% human plasma in PBS (1
ml) were incubated with 125I-M1 protein (105
cpm/ml, approximately 1 ng) in the absence
or presence of nonlabeled M1 protein for 30
min at 37C. Samples were centrifuged and
the radioactivity of the pellets was measured.
The percentage of added total radioactivity
measured in the pellets is given and the figure
shows the mean  SD of three independent
experiments, each done in duplicate.
(B) Human whole blood was treated with M1
protein for 30 min at 37C. Cells were centri-
fuged and the amount of HBP in the superna-
tants was determined.
(C) One ml samples of human plasma (10%
in PBS) or fibrinogen (300 g/ml in PBS) were
incubated with 125I-M1 protein (105 cpm/ml,
approximately 1 ng) in the absence or pres-
ence of nonlabeled M1 protein. After 30 min of
incubation at 37C, samples were centrifuged
and the radioactivity of the pellets was mea-
sured. Results are presented as percentage
of added total radioactivity. The figure pre-
sents the mean  SD of three independent
experiments, each done in duplicate.
(D) Scanning electron microscopy of plasma
clots induced by the addition of M1 protein
(top) or thrombin (bottom). Bar is equal to
5 m.
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and M1 protein/fibrinogen complexes activates the PMNs in a mixture of plasma and M1 protein. In contrast,
Gly-His-Arg-Pro did not influence the aggregation ofcells, which causes HBP release. The data described
above show that M1 protein/fibrinogen complexes bind PMNs. These results support the notion that M1 protein/
fibrinogen complexes activate PMNs through 2 integrinto PMNs and induce their aggregation and activation,
resulting in HBP release. crosslinking, which triggers the release of HBP. This
mechanism appears to be similar to the previously de-
scribed antibody-mediated crosslinking of CD11b/CD18M1 Protein-Induced HBP Release Is Blocked
by a 2 Integrin Antagonist that mimics adhesion-dependent receptor engagement
and causes a massive release of HBP from PMNs (Gau-Human fibrinogen binds to PMNs via 2 integrins (Altieri,
1999) and for CD11c/CD18 the binding site was mapped tam et al., 2000, 2001).
to the NH2-terminal region of the A chain of fibrinogen.
A peptide derived from this region (Gly-Pro-Arg-Pro) Intravenous Injection of M1 Protein into Mice
Causes Severe Lung Lesions that Arehas been shown to block adherence of TNF-stimulated
PMNs to fibrinogen-coated surfaces, while other pep- Prevented by the Administration
of a 2 Integrin Antagonisttides from the same region, including Gly-His-Arg-Pro,
had no effect (Loike et al., 1991). Furthermore, it was Previous work has identified HBP in humans and pigs
(Flodgaard et al., 1991). Before mouse experiments weredemonstrated that antibodies against 2 integrins inhibit
the binding of fibrinogen to activated PMNs, and among performed, we investigated if mice also produce a ho-
molog of HBP. To this end, bone marrow cells from micethose antibodies, a monoclonal antibody (IB4) directed
against the common -chain of integrins, was the most were isolated and the existence of such an HBP homolog
was demonstrated by RT-PCR analysis using a primerpotent (Loike et al., 1991). Platelet-induced activation of
PMNs was also found to be dependent on the interaction set derived from human HBP and by Western blot analy-
sis using antibodies against human HBP (data notbetween CD11c/CD18 and the A chain of platelet-
expressed fibrinogen (Ruf and Patscheke, 1995). As shown). A series of animal experiments was now con-
ducted to determine if the effects observed in vitro couldshown for the binding of fibrinogen to PMNs, platelet-
induced activation of PMNs was also inhibited by the relate to pathophysiological conditions reported during
severe infection. Mice (three animals per group) receivedGly-Pro-Arg-Pro peptide and by antibodies to CD11c,
whereas the Gly-His-Arg-Pro peptide had no effect (Ruf M1 protein i.v. (15 g/animal), a mixture of M1 protein
(15 g/animal) and peptide Gly-Pro-Arg-Pro (400 g/and Patscheke, 1995). These reports demonstrate that
the binding of PMNs to immobilized fibrinogen (for in- animal), or a mixture of M1 protein (15 g/animal) and
peptide Gly-His-Arg-Pro (400 g/animal). Alternatively,stance on coverslips or platelets) involves 2 integrins
leading to an activation of PMNs. We therefore tested animals were treated with protein H (15 g/animal) or
vehicle alone. Thirty minutes after administration thethe Gly-Pro-Arg-Pro and Gly-His-Arg-Pro peptides, as
well as an antibody against the 2 integrins (IB4), for their breathing of mice injected with M1 protein or M1 protein
plus peptide Gly-His-Arg-Pro was clearly affected asability to interfere with the M1 protein-induced release of
HBP. As shown in Figure 4B, the addition of Gly-Pro- compared to the other groups of mice. Animals were
sacrificed and the lungs were removed, stained withArg-Pro to human blood blocked the mobilization of
HBP by M1 protein in a dose-dependent manner, and hematoxylin and eosin and subjected to light micros-
copy, or analyzed by scanning electron microscopy.the IB4 antibody directed against the common -chain
of integrins also impaired HBP release. The control sub- Figure 5A depicts a representative lung sample from a
mouse injected with buffer only, showing intact lungstances, Gly-His-Arg-Pro and an unrelated antibody
against H-kininogen, did not influence HBP secretion tissue. Lung sections from mice injected with M1 pro-
tein, however, demonstrate severe hemorrhage and tis-(Figure 4B). As an additional control, antibodies against
complement receptors 1 and 3, and the complement sue destruction (Figure 5B). These lesions were almost
completely prevented when M1 protein was injectedinhibitor compstatin were tested. No interference with
HBP release was recorded (data not shown), suggesting together with Gly-Pro-Arg-Pro, even though the tissue
was slightly swollen, indicating an inflammatory reactionthat complement does not participate in the release
process. The effect of Gly-Pro-Arg-Pro on M1 protein- (Figure 5C). By contrast, application of Gly-His-Arg-Pro
could not prevent the M1 protein-induced bleeding andinduced PMN aggregation was analyzed by scanning
electron microscopy. As shown in Figure 4C (middle tissue destruction (Figure 5D). Protein H was injected
as a control and analysis of the lung tissue revealed noimage), Gly-Pro-Arg-Pro inhibited the aggregation of
Figure 4. Binding of M1 Protein/Fibrinogen Complexes to 2 Integrins Activates PMNs
(A) PMNs preincubated with a mixture of M1 protein (1 g/ml) and human plasma (10% in PBS) were analyzed by scanning electron microscopy
(upper left). Purified PMNs (upper right), PMNs incubated with plasma (lower left) or M1 protein alone (lower right), are shown. Bar is equal
to 10 m.
(B) M1 protein was added to whole human blood (1 g/ml) followed by the addition of different amounts of Gly-Pro-Arg-Pro, Gly-His-Arg-
Pro, monoclonal antibody IB4 to CD18, or antibody AS88 (directed against human H-kininogen). After 30 min of incubation at 37C, cells were
spun down and the amount of HBP in the supernatants was determined. Data are expressed as percent of HBP release in blood induced by
M1 protein alone, and the bars represent means  SD of three experiments, each done in duplicate.
(C) Electron microscopy of purified PMNs in a mixture of plasma and M1 protein (left image). In the other images, fibrinogen-derived peptides
Gly-Pro-Arg-Pro (middle image) or Gly-His-Arg-Pro (right image), were added to the mixture of plasma and M1 protein, prior to the incubation
with PMNs. Bar is equal to 10 m.
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Figure 5. M1 Protein Induces Severe Lung
Lesions in Mice
Light microscopy (A–E) and scanning elec-
tron microscopy (F–J) of murine lung tissue
sections are presented. The figure shows
representative micrographs of lungs from
mice injected i.v. with buffer alone (A and F),
M1 protein (B and G), M1 protein and peptide
Gly-Pro-Arg-Pro (C and H), M1 protein and
peptide Gly-His-Arg-Pro (D and I), or with pro-
tein H (E and J). Bars represent 50 m (A–E)
and 5 m (F and J).
hemorrhage and the alveoli were less swollen in these activate PMNs via the 2 integrins, which causes mas-
sive vascular leakage and deposition of protein aggre-mice (Figure 5E). In order to investigate lung tissue at
higher magnification, tissue sections were also analyzed gates in the lung tissue. The results also show that the
pathophysiological effect of the complexes is blockedby scanning electron microscopy. Figure 5F shows a
lung section from a PBS-treated mouse with no signs when fibrinogen-induced crosslinking of 2 integrins is
prevented by the Gly-Pro-Arg-Pro peptide.of pulmonary damage. However, injection of M1 protein
resulted in severe leakage of erythrocytes as seen be-
fore, but also in the deposition of proteinous aggregates The Gly-Pro-Arg-Pro Peptide Prevents Vascular
Leakage and Lung Damage in Mice Infected(Figure 5G). The morphology of the aggregates resem-
bles the M1 protein-induced amorphous plasma precipi- with M1 Protein-Expressing S. pyogenes Bacteria
In a second series of animal experiments, nine mice weretates seen in Figure 4C (left image). The lungs of mice
injected with M1 protein and Gly-Pro-Arg-Pro contained subcutaneously infected with M1 protein-expressing S.
pyogenes bacteria in PBS. Three mice were treated withno precipitates, but some alveolar swelling and minor
leakage of erythrocytes were observed indicating an either peptide Gly-Pro-Arg-Pro or Gly-His-Arg-Pro as
described in Experimental Procedures, while three miceinflammatory reaction (Figure 5H). In contrast, treatment
with Gly-His-Pro-Arg did not influence M1 protein- received only the bacterial suspension. As a negative
control, three mice were given a subcutaneous injectioninduced lung damage (Figure 5I). The injection of protein
H did neither cause serious bleeding nor did the tissue of PBS. Six hours after infection, animals were sacri-
ficed, blood samples were taken, and lungs were re-appear to be inflamed (Figure 5J). The animal experi-
ments suggest that M1 protein/fibrinogen complexes moved and examined by scanning electron microscopy.
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Figure 6. Analysis of Lung Tissue from Mice
Subcutaneously Infected with S. pyogenes
Scanning electron microscopy of lung sec-
tions derived from mice subcutaneously in-
jected with PBS (A), infected with S. pyogenes
without treatment (B), or treated with Gly-Pro-
Arg-Pro (C) or Gly-Pro-Arg-Pro (D). Immuno-
detection with anti-M1 protein antibodies in
lung tissue from mice injected with PBS (E)
or S. pyogenes bacteria (F). Bright areas con-
taining gold-labeled antibodies are marked
by arrows. Bars represent 5 m (A–D) and 25
m (E and F).
No bacterial growth was recorded in the blood samples necrotizing fasciitis, a deep and extensive soft tissue
infection resembling the subcutaneous murine model offrom the animals, indicating that during this 6 hr period
the bacteria had not yet disseminated from the local infection described above. We therefore investigated
whether M1 protein/fibrinogen complexes could be de-site of infection. Figures 6A–6D show electron micro-
graphs of representative lung tissue sections from these tected in biopsies from infected soft tissue obtained
from a patient with necrotizing fasciitis and STSS. Tissueanimals. Recovered lungs from mice that received buffer
alone (Figure 6A) showed no signs of pulmonary dam- sections were analyzed by confocal immunofluores-
cence microscopy using antibodies against M1 proteinage. However, mice that were infected with streptococci
were suffering from severe lung lesions characterized and fibrinogen. Numerous streptococci are found at the
epicenter of the infection, and although some M1 proteinby protein deposits (Figure 6B). When infected animals
were treated with Gly-Pro-Arg-Pro, the lung tissue was is still associated with the bacteria, most has been re-
leased into the tissue (Figure 7). Importantly, the shed-much less affected (Figure 6C), whereas treatment with
Gly-His-Arg-Pro failed to prevent pulmonary lesions ded M1 protein colocalized with fibrinogen, demonstra-
ting that the amount of M1 protein at the site of infection(Figure 6D). Lung tissue from these mice was also ana-
lyzed by immunostaining and scanning electron micros- is sufficient to allow the formation of large M1 protein/
fibrinogen complexes. M1 protein was not detected incopy using antibodies against M1 protein which were
detected by gold labeled secondary antibodies. Figure biopsies from distal and noninfected tissue of this pa-
tient (data not shown). These observations in a human6F shows that M1 protein is present in the infiltrated
tissue as indicated by colloidal gold staining of fibrin patient with severe streptococcal disease underline the
potential pathophysiological significance of M1 protein/deposits, which appear as bright areas. In contrast, no
M1 protein was detected in lungs from noninfected ani- fibrinogen complexes generated at the infectious focus.
mals (Figure 6E). Finally, no bacteria were observed in
the lungs of infected or noninfected mice. The results Discussion
demonstrate that before the infection has disseminated
from its local subcutaneous site, protein complexes Over the last two decades a worldwide increase in se-
vere infections caused by S. pyogenes has attractedcontaining M1 protein are transported to the lungs,
where they induce severe vascular leakage. considerable concern in the research community. The
dramatic nature and the high mortality of these infec-
tions have also raised public awareness of these dis-M1 Protein/Fibrinogen Precipitates Are Formed
in a Patient with Necrotizing Fasciitis and eases. Severe invasive S. pyogenes infections are asso-
ciated with disturbed microcirculation, hypotension,Streptococcal Toxic Shock Syndrome (STSS)
STSS is a clinical condition associated with high morbid- shock, and organ failure. Several virulence factors of S.
pyogenes, including pyrogenic exotoxins A, B, and C,ity and mortality (for a review, see Stevens, 2003).
Cardinal symptoms of STSS are hypovolemic hypoten- and more recently identified superantigens with strong
mitogenic activity (for references, see review by Cun-sion and respiratory failure. The syndrome is commonly
preceded by a focal infection and in some cases by ningham, 2000), contribute to the pathogenesis of this
Cell
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Figure 7. M1 Protein and Fibrinogen Colocalize at the Site of S. pyogenes Infection in Biopsies from a Patient with Necrotizing Fasciitis and
Toxic Shock Syndrome
Tissue biopsies obtained from a patient with necrotizing fasciitis and STSS caused by an M1 strain, were stained for S. pyogenes, the M1
protein and fibrinogen, and analyzed by confocal microscopy as detailed in Experimental Procedures. The figure shows simulated maximum
projections of a sequential scan. The M1 protein is shown in red, fibrinogen in green, and yellow stain illustrates areas with colocalized M1
and fibrinogen. Cellular infiltrates are indicated in blue by the nuclear stain DAPI.
(A) Extensive colocalization of M1 and fibrinogen is noted in biopsies collected at the epicenter of infection, which contain high amount of S.
pyogenes as evident by staining for Lancefield group A carbohydrate (see insert). The arrows indicate M1 protein-coated streptococci of a
size of 1–1.3m. The area indicated by the white rectangle was analyzed at a higher magnification in B–D.
(B) Released M1 protein (red) localized next to an area of streptococci stained in blue by the DNA binding stain DAPI. The size of the blue-
stained bacteria, 0.8 m, corresponds to that reported for streptococci.
(C) Fibrinogen (green) and (D) colocalization of M1 and fibrinogen (yellow areas).
condition designated streptococcal toxic shock syn- of type-specific anti-M protein antibodies, M protein-
expressing S. pyogenes survive and grow in humandrome, STSS (Cone et al., 1987), by triggering the induc-
tion of proinflammatory cytokines. It was demonstrated blood (Lancefield, 1969). In cases of STSS, the M1 sero-
type is the most prevalent, and a particular subclone ofthat the propensity of the host to mount a high or low
cytokine response to superantigens was directly and M1 has globally disseminated and been the dominating
strain in these infections for more than twenty yearssignificantly correlated to the disease severity (Norrby-
Teglund et al., 2000). Interestingly, STSS is associated (Davies et al., 1996). Moreover, patients dying from STSS
caused by M1 strains were found to have low antibodywith specific HLA class II haplotypes, explaining why
some individuals develop lethal S. pyogenes disease, titers toward the M1 protein (Holm et al., 1992). These
observations all suggest that the M1 protein participateswhereas other are barely affected when infected with
the same streptococcal subclone (Kotb et al., 2002). in molecular events, which contribute to this devastating
clinical condition. However, it should be stressed thatA multitude of host-microbe interactions determine
the outcome of S. pyogenes infections and considerable the overwhelming majority of S. pyogenes infections,
including those caused by M1 strains, are noncompli-scientific effort has been investigated to unravel the
complexity of this molecular relationship. For instance, cated throat and skin infections, indicating that several
molecular events have to act in concert for STSS to de-recent work has identified an important cytolysin-medi-
ated secretion system in S. pyogenes (Madden et al., velop.
The gene encoding the M1 protein has been se-2001), whereas another study described a sophisticated
mechanism for tissue invasion by the bacteria through quenced in different M1 isolates and a comparison
showed more than 95 percent sequence identity (A˚kes-CD44-mediated cell signaling (Cywes and Wessels,
2001). As mentioned, the M protein is one of the classical son et al., 1994; Harbaugh et al., 1993). The binding of
fibrinogen to different M1 strains underlines this struc-virulence determinants of S. pyogenes. M proteins form
-helical coiled-coil dimers, which appear as hair-like tural conservation. Thus, when 43 M1 isolates were
tested, including isolates from patients with STSS, allstructures at the bacterial surface. Based on extensive
sequence variation in the NH2-terminal region extending showed high binding of radiolabeled fibrinogen (L.B.
and I.-M. Frick, unpublished data). The affinity betweenfrom the bacterial surface, isolates of S. pyogenes can
be divided into more than 80 serotypes. In the absence M1 protein and fibrinogen has been determined and the
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equilibrium constant is high; 1.1  1010 M1 (A˚kesson et cells in STSS patients, who exhibit a strikingly high per-
al., 1994). This fact and the presence of two fibrinogen centage (40%–50%) of immature PMNs (Stevens, 1995).
binding so-called B domains in the M1 protein (A˚kesson Intravenous injection will target a substance to the
et al., 1994; Ringdahl et al., 2000), explain the rapid lungs, and small amounts of M1 protein administrated
formation of M1 protein/fibrinogen complexes in plasma i.v. to mice induced severe lung lesions in the animals.
described here. Apart from isolates of the M1 serotype, Observations made in our murine model of subcutane-
M3 strains are the most common in patients with STSS, ous S. pyogenes infection, demonstrate that M1 protein
and it is notable that the M3 protein also has two repeats, is present in the lungs and that vascular leakage is in-
which are homologous to the B domains of M1 protein, duced before the bacteria can be found in the blood-
and that M1 and M3 strains bind fibrinogen to the same stream or in the lungs. This and the finding that M1
extent (L.B. and H.H., unpublished data). protein/fibrinogen complexes are detected in infected
In the present study, M1 protein/fibrinogen complexes tissue from a patient with necrotizing fasciitis, further
were found to activate neutrophils leading to HBP re- support a role for these protein complexes in the induc-
lease, presumably by crosslinking 2 integrins. M pro- tion of pulmonary vascular leakage. Endothelial cells
teins are typically associated with the bacterial cell wall, lining the vasculature form a fragile barrier between the
but at least in the case of M1 protein, several mecha- blood and the interstitium of the lung. During an inflam-
nisms have been reported that cause the release of the matory disease state, extravascular leakage of fluids
protein. For instance, S. pyogenes secretes a cysteine and macromolecules, fibrin deposition, and infiltration
proteinase (SpeB), which efficiently solubilizes fibrino- of red and white blood cells, can result in a functional
gen binding fragments of the M1 protein (Berge and reduction of the alveolar space, eventually leading to
Bjo¨rck, 1995). Moreover, when grown under conditions respiratory failure. In particular, activated PMNs are be-
not allowing the production of SpeB, substantial amounts lieved to contribute to the leakage and vascular injury
(0.4–0.6 mg/l) of M1 protein can be isolated from the in this condition, which in severe cases is connected
culture medium (A˚kesson et al., 1994). Finally, this work with high mortality rates. In relation to the M1 protein-
demonstrates that PMN-derived proteinases cleave and induced lung lesions described here, it is noteworthy
release fibrinogen binding M1 protein fragments, and that severe pulmonary hemorrhages have been reported
shedded M1 protein was also found in the infected soft in patients with fulminant S. pyogenes infections (Ooe
tissue of a patient suffering from necrotizing fasciitis et al., 1999), and that respiratory failure is a major and
and STSS. Compared to most other human bacterial common complication in cases of STSS (Stevens, 1995).
pathogens, S. pyogenes infections give rise to an intense The formation of M1 protein/fibrinogen complexes,
local inflammation, which will attract PMNs and induce their interaction with 2 integrins resulting in the activa-
plasma exudation at the site of infection. This will in tion of PMNs, and the subsequent release of leakage-
turn, promote the formation of M1 protein/fibrinogen inducing HBP, represent a chain of events which may
complexes and further enhance the local inflammatory explain the extremely rapid progress of STSS and the
response. Via the bloodstream such complexes and/or severity of the syndrome. The identification of this po-
bacteria with surface bound fibrinogen could be depos- tentially important pathophysiological pathway and the
ited in various organs and induce plasma leakage by observation that a peptide interfering with the interac-
local activation of PMNs and release of HBP. tion between fibrinogen and 2 integrins, prevents M
Increased vascular permeability is a fundamental protein-induced lung lesions, suggest that the data de-
pathophysiological mechanism in shock. In STSS, the scribed here could be helpful in the development of
leakage of plasma from the capillaries into the tissue is therapeutic strategies in STSS. The fact that 30–70 per-
excessive and these patients require massive amounts cent of patients suffering from this condition die in spite
(10–20 liters/day) of intravenous fluids. Several previous of aggressive modern therapy (Stevens, 1995), empha-
investigations have shown (for a review, see Edens and
sizes the urgent need for more efficient treatments.
Parkos, 2003) that activated PMNs induce vascular leak-
age, and a recent study demonstrated that among the
Experimental Proceduresvarious substances released by activated PMNs, HBP
is entirely responsible for this effect (Gautam et al., Reagents
2001). As shown here, crosslinking of 2 integrins by M1 Neutrophil Isolation Medium (NIM) was purchased from Cardinal
protein/fibrinogen complexes, results in the activation Associates Inc. (Santa Fe, NM). RPMI 1640 medium with Glutamax
I, Minimum Essential Medium (MEM) with Earle’s salts and L-gluta-of PMNs followed by the release of HBP. Moreover, after
mine, fetal bovine serum, and penicillin/streptomycin solution werei.v. injection of M1 protein into mice and subcutaneous
purchased from Life Technologies (Ta¨by, Sweden). Ionomycin andinfection with S. pyogenes, microscopical analysis re-
formyl-methionyl-leucyl-phenylalanine were obtained from Calbio-
vealed the presence of blood cells and protein aggre- chem (La Jolla, CA). The acetoxymethyl ester of N,N-(1,2-ethane-
gates in the lung tissue. This resembles a mechanism diylbis(oxy-2,1-phenylene))bis(N-(carboxymethyl)) (BAPTA), and Pro-
referred to as “frustrated phagocytosis” where PMNs Long Antifade Kit were from Molecular Probes (Eugene, OR).
are activated at a surface, or they are attempting to 4-(2-hydroxyethyl)-1-piperazineethanesulphonic acid (HEPES) was
from Merck (Whitehouse Station, NJ). Streptococcal cysteine pro-phagocytose a particle that is too large. As a conse-
teinase (SpeB) zymogen was purified as described earlier (Bergequence, these immobilized and activated PMNs will re-
and Bjo¨rck, 1995). Recombinant M1 protein, fragments A-S andlease leakage-inducing HBP and other proinflammatory
S-C3, and protein H were expressed in E. coli and purified (A˚kesson
mediators, such as oxidative metabolites and proteo- et al., 1994), and recombinant human HBP was also produced and
lytic enzymes, which will further increase the tissue dam- purified as previously described (Rasmussen et al., 1996). Lipotei-
age. The significance of PMNs in the development of choic acid (LTA), hyaluronic acid (HA), and bovine serum albumin
(BSA) were from Sigma Chemical Co. (St. Louis, MO). Mouse mABSTSS is further underlined by the rapid turnover of these
Cell
378
2F23C3 and rabbit antiserum (409A) to recombinant HBP were pre- buffer for 1 hr at room temperature. Specimens were subsequently
washed, incubated with an antiserum against M1, washed, incu-pared and purified as described earlier (Lindmark et al., 1999) and
peroxidase-conjugated goat antirabbit IgG was from Bio-Rad Labo- bated with a secondary antibody (antirabbit IgG) coupled to 10 nm
colloidal gold, followed by a final washing and then fixation stepratories (Richmond, CA). Peptides Gly-Pro-Arg-Pro and Gly-His-
Arg-Pro were purchased from Bachem Feinchemikalien AG (Buben- with 2.5% glutaraldehyde in cacodylate buffer. After fixation, sam-
ples were washed, dehydrated, critical point dried, sputtered withdorf, Switzerland). Fluanison/fentanyl and midazolam were from
Janssen Pharmaceutica, Beers, Belgium and Hoffman-La Roche, palladium/gold as described earlier (Herwald et al., 2003). Samples
were examined in a Jeol JSM-350 scanning electron microscope.Basel, Switzerland.
Alternatively, samples for immunolabeling were coated with a thin
layer of carbon instead of palladium/gold prior to scanning elec-Cell Culture, Neutrophil Isolation, and Stimulation of Cells
tron microscopy.Human PMNs were isolated from fresh heparinized blood of healthy
volunteers using NIM, a single step density gradient medium, ac-
Animal Experimentscording to the instructions supplied by the manufacturer. Neutrophil
Adult female mice (approximately 20 g) of the Balb/c strain wereproteinase release was induced by PMN activation through antibody
used. Animals were anaesthetized as described (Persson et al.,crosslinking of CD11b/CD18 as described previously (Gautam et
2003). Mice were given an intravenous injection of 100l of a solutional., 2000).
containing 150 g/ml M1 protein. Alternatively, 100 l of solutions
containing 150 g/ml M1 protein plus 4 mg/ml Gly-Pro-Arg-Pro orBacterial Strains
Gly-His-Arg-Pro were injected intravenously. As a control, vehicleThe AP1 strain used in this study is the 40/58 S. pyogenes strain
alone was injected. Thirty min after injection, mice were sacrificedfrom the WHO Collaborating Centre for references and Research
and the lungs were removed. Alternatively, 100 l of a bacteriaon Streptococci, Institute of Hygiene and Epidemiology, Prague,
solution (2  109 AP1 bacteria/ml PBS in the presence or absenceCzech Republic. The MC25 strain is an isogenic AP1 mutant strain,
of 400 g Gly-Pro-Arg-Pro or Gly-His-Arg-Pro) were injected to-devoid of surface-associated M1 protein (Collin and Olse´n, 2000).
gether with 0.9 ml of air into the dorsal region of the mouse. After
30 min, mice were given an intraperitoneal injection of 100 l of aEnzymatic Treatment of S. pyogenes
solution containing PBS or 2 mg/ml Gly-Pro-Arg-Pro or Gly-His-S. pyogenes bacteria (strain AP1) were grown in Todd-Hewitt broth
Arg-Pro, respectively. Six hours after infection, mice were sacrificed(Difco, Detroit, MI) at 37C for 16 hr and harvested by centrifugation
and the lungs were removed.at 3000  g for 20 min. The bacteria were washed twice in PBS
and resuspended in PBS to 2  1010 cells/ml. Various amounts of
Histochemistrysecretion products from PMNs were added to bacterial suspensions
Mice were sacrificed, lungs rapidly removed and fixed at 4C for 24followed by incubation for 2 hr at 37C. Bacteria were spun down
hr in buffered 4% formalin (pH 7.4; Kebo). Tissues were dehydratedat 3000  g for 20 min, and the resulting pellets and supernatants
and imbedded in paraffin (Histolab Products AB), cut into 4 mwere saved. Digestions were terminated by the addition of SDS
sections, and mounted. After removal of the paraffin, tissues weresample buffer containing 5% 2-mecaptoethanol.
stained with Mayers hematoxylin (Histolab Products AB) and eosin
(Surgipath Medical Industries, Inc.).SDS-Polyacrylamide Gel Electrophoresis,
Western Blotting, and Immunoprinting
Immunofluorescence and Confocal MicroscopyProteins were separated by 12.5% (w/v) polyacrylamide gel electro-
Snap-frozen biopsies of tissue, collected either from the epicenterphoresis in the presence of 1% (w/v) SDS (Laemmli, 1970). Proteins
of infection (fascia) or from a distal site with no evidence of inflamma-were transferred onto nitrocellulose membranes for 30 min at 100
tion (muscle), from a patient with necrotizing fasciitis and toxic shockmA. The membranes were blocked with PBS containing 5% (w/v)
syndrome caused by an M1T1 S. pyogenes strain (kindly provideddry milk powder and 0.05% (w/v) Tween-20, [pH 7.4]. Membranes
by Prof. Donald E. Low, Mount Sinai Hospital, Toronto, Canada) werewere probed with a polyclonal antibody against M1 protein, diluted
cryosectioned, fixed, and immunostained as previously described1:50,000 in the blocking buffer, was used. Bound antibodies were
(Norrby-Teglund et al., 2001). Staining for the M1 protein wasdetected using peroxidase-conjugated secondary antibodies against
achieved by incubation with a polyclonal rabbit antiserum againstrabbit IgG (dilution 1:3000) followed by a chemiluminescence detec-
M1 (diluted 1:10 000), double staining for fibrinogen was obtainedtion method. Alternatively, membranes were blocked, incubated
through direct labeling of purified rabbit antihuman fibrinogen anti-with fibrinogen (2 g/ml), followed by immunodetection with rabbit
bodies diluted to a concentration of 3 mg/ml (Dakocytomation) byantibodies to fibrinogen (1:1000) and peroxidase-conjugated sec-
Zenon Alexa fluor 532 IgG labeling kit (Molecular Probes). A poly-
ondary antibodies against rabbit immunoglobulin (1:3000 diluted).
clonal rabbit antiserum against the Lancefield group A carbohydrate
was used to detect S. pyogenes (Norrby-Teglund et al., 2001). Single
Determination of HBP stainings were performed to assure specificity of staining patterns.
For evaluation, the Leica confocal scanner TCS2 AOBS with an
100 l human blood were diluted in PBS to a final volume of 1.0 ml inverted Leica DMIRE2 microscope was used.
and incubated with various PMNs-activating components for 30 min
at 37C. Cells were centrifuged (300 g for 15 min) and the resulting Acknowledgments
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